National HealthCare Corp (NHC) stock
NHCNYSEServices-Skilled Nursing Care FacilitiesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 20/3018% above fair value
$201.60−4.17 (-2.03%)
Close on Nov 18, 2026Market cap $3.16BP/E 22.7Yield 1.25%
National HealthCare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
National HealthCare's revenue for the twelve months ending Jun 30, 2026 was $1.56B, up 6.9% year over year. For fiscal 2025 it was $1.52B, up 16.1% from the year before. The highest annual figure on record is $1.52B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | +16.1% |
| FY2024 | Dec 31, 2024 | $1.31B | +14.5% |
| FY2023 | Dec 31, 2023 | $1.14B | +5.1% |
| FY2022 | Dec 31, 2022 | $1.09B | +1.1% |
| FY2021 | Dec 31, 2021 | $1.07B | +4.5% |
| FY2020 | Dec 31, 2020 | $1.03B | +3.2% |
| FY2019 | Dec 31, 2019 | $996.38M | +1.6% |
| FY2018 | Dec 31, 2018 | $980.35M | +1.7% |
| FY2017 | Dec 31, 2017 | $963.90M | +4.4% |
| FY2016 | Dec 31, 2016 | $923.58M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $408.03M | +8.8% |
| Q1 FY2026 | Mar 31, 2026 | $381.82M | +2.2% |
| Q4 FY2025 | Dec 31, 2025 | $386.51M | +4.6% |
| Q3 FY2025 | Sep 30, 2025 | $382.66M | +12.5% |
| Q2 FY2025 | Jun 30, 2025 | $374.91M | +24.7% |
| Q1 FY2025 | Mar 31, 2025 | $373.70M | +25.7% |
| Q4 FY2024 | Dec 31, 2024 | $369.35M | +22.7% |
| Q3 FY2024 | Sep 30, 2024 | $340.20M | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $300.66M | +6.4% |
| Q1 FY2024 | Mar 31, 2024 | $297.18M | +10.2% |
| Q4 FY2023 | Dec 31, 2023 | $300.91M | +13.7% |
| Q3 FY2023 | Sep 30, 2023 | $288.49M | +6.5% |
| Q2 FY2023 | Jun 30, 2023 | $282.58M | +4.1% |
| Q1 FY2023 | Mar 31, 2023 | $269.56M | -3.4% |
| Q4 FY2022 | Dec 31, 2022 | $264.55M | -6.7% |
| Q3 FY2022 | Sep 30, 2022 | $270.84M | -2.1% |
| Q2 FY2022 | Jun 30, 2022 | $271.36M | +3.1% |
| Q1 FY2022 | Mar 31, 2022 | $278.98M | +11.2% |
| Q4 FY2021 | Dec 31, 2021 | $283.43M | +9.1% |
| Q3 FY2021 | Sep 30, 2021 | $276.74M | +10.4% |
| Q2 FY2021 | Jun 30, 2021 | $263.16M | +0.6% |
| Q1 FY2021 | Mar 31, 2021 | $250.97M | -2.0% |
| Q4 FY2020 | Dec 31, 2020 | $259.83M | +2.3% |
| Q3 FY2020 | Sep 30, 2020 | $250.63M | +1.4% |
| Q2 FY2020 | Jun 30, 2020 | $261.64M | +5.9% |
| Q1 FY2020 | Mar 31, 2020 | $256.12M | +3.2% |
| Q4 FY2019 | Dec 31, 2019 | $253.88M | +2.0% |
| Q3 FY2019 | Sep 30, 2019 | $247.07M | +0.3% |
| Q2 FY2019 | Jun 30, 2019 | $247.15M | +2.1% |
| Q1 FY2019 | Mar 31, 2019 | $248.29M | +2.2% |
| Q4 FY2018 | Dec 31, 2018 | $248.92M | +1.1% |
| Q3 FY2018 | Sep 30, 2018 | $246.33M | +2.1% |
| Q2 FY2018 | Jun 30, 2018 | $242.14M | +1.4% |
| Q1 FY2018 | Mar 31, 2018 | $242.96M | +1.9% |
| Q4 FY2017 | Dec 31, 2017 | $246.31M | – |
| Q3 FY2017 | Sep 30, 2017 | $241.20M | – |
| Q2 FY2017 | Jun 30, 2017 | $238.70M | – |
| Q1 FY2017 | Mar 31, 2017 | $238.54M | – |
See a number that looks wrong?